Bai Y, Wu X, Shen Y, Wang L, Cheng Z, Sun Y
Viruses. 2025; 17(2).
PMID: 40006992
PMC: 11861675.
DOI: 10.3390/v17020237.
Bodenstein C, Bourquain D, Nitsche A, Grossegesse M
J Med Virol. 2025; 97(2):e70246.
PMID: 39977402
PMC: 11841928.
DOI: 10.1002/jmv.70246.
Abidi S, Elhazaz Fernandez A, Seehase N, Hanisch L, Karlas A, Sandig V
Vaccines (Basel). 2025; 12(12.
PMID: 39772039
PMC: 11680203.
DOI: 10.3390/vaccines12121377.
Lynch J, Layne C, Cao J
Methods Mol Biol. 2024; 2860:131-147.
PMID: 39621265
DOI: 10.1007/978-1-0716-4160-6_9.
Li Z, Liu R
Methods Mol Biol. 2024; 2860:83-95.
PMID: 39621262
DOI: 10.1007/978-1-0716-4160-6_6.
Vaccinia virus subverts xenophagy through phosphorylation and nuclear targeting of p62.
Krause M, Samolej J, Yakimovich A, Kriston-Vizi J, Huttunen M, Lara-Reyna S
J Cell Biol. 2024; 223(6).
PMID: 38709216
PMC: 11076808.
DOI: 10.1083/jcb.202104129.
An IRF2-Expressing Oncolytic Virus Changes the Susceptibility of Tumor Cells to Antitumor T Cells and Promotes Tumor Clearance.
Shao L, Srivastava R, Delgoffe G, Thorne S, Sarkar S
Cancer Immunol Res. 2024; 12(6):779-790.
PMID: 38517470
PMC: 11150089.
DOI: 10.1158/2326-6066.CIR-23-0573.
Transgene expression knock-down in recombinant Modified Vaccinia virus Ankara vectors improves genetic stability and sustained transgene maintenance across multiple passages.
Neckermann P, Mohr M, Billmeier M, Karlas A, Boilesen D, Thirion C
Front Immunol. 2024; 15:1338492.
PMID: 38380318
PMC: 10877035.
DOI: 10.3389/fimmu.2024.1338492.
Markerless bacterial artificial chromosome manipulation method by red proteins of phage λ mediated homologous recombination utilizing fluorescent proteins for both positive and counter selection.
Yoshikawa T, Misu M, Kurosu T, Takamatsu Y, Sugimoto S, Shimojima M
Heliyon. 2023; 9(8):e18983.
PMID: 37600421
PMC: 10432722.
DOI: 10.1016/j.heliyon.2023.e18983.
Time- and cost-effective production of untagged recombinant MVA by flow virometry and direct virus sorting.
Boselli D, Panigada M, Di Terlizzi S, Romano M, Canonico E, Villa C
J Transl Med. 2023; 21(1):495.
PMID: 37482614
PMC: 10364397.
DOI: 10.1186/s12967-023-04353-7.
Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy.
Martin N, Crupi M, Taha Z, Poutou J, Whelan J, Vallati S
Pharmaceuticals (Basel). 2023; 16(5).
PMID: 37242495
PMC: 10224353.
DOI: 10.3390/ph16050709.
Lumpy Skin Disease-An Emerging Cattle Disease in Europe and Asia.
Whittle L, Chapman R, Williamson A
Vaccines (Basel). 2023; 11(3).
PMID: 36992162
PMC: 10057024.
DOI: 10.3390/vaccines11030578.
Generation of Multiple Arbovirus-like Particles Using a Rapid Recombinant Vaccinia Virus Expression Platform.
Wang Y, Griffiths A, Brackney D, Verardi P
Pathogens. 2022; 11(12).
PMID: 36558839
PMC: 9785247.
DOI: 10.3390/pathogens11121505.
Poxviruses capture host genes by LINE-1 retrotransposition.
Fixsen S, Cone K, Goldstein S, Sasani T, Quinlan A, Rothenburg S
Elife. 2022; 11.
PMID: 36069526
PMC: 9578705.
DOI: 10.7554/eLife.63332.
Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and Camels.
Alharbi N, Aljamaan F, Aljami H, Alenazi M, Albalawi H, Almasoud A
Vaccines (Basel). 2022; 10(8).
PMID: 36016218
PMC: 9413082.
DOI: 10.3390/vaccines10081330.
Intranasal Immunization with a Vaccinia Virus Vaccine Vector Expressing Pre-Fusion Stabilized SARS-CoV-2 Spike Fully Protected Mice against Lethal Challenge with the Heavily Mutated Mouse-Adapted SARS2-N501Y Strain of SARS-CoV-2.
Kibler K, Szczerba M, Lake D, Roeder A, Rahman M, Hogue B
Vaccines (Basel). 2022; 10(8).
PMID: 35893821
PMC: 9394475.
DOI: 10.3390/vaccines10081172.
Poxviruses package viral redox proteins in lateral bodies and modulate the host oxidative response.
Bidgood S, Samolej J, Novy K, Collopy A, Albrecht D, Krause M
PLoS Pathog. 2022; 18(7):e1010614.
PMID: 35834477
PMC: 9282662.
DOI: 10.1371/journal.ppat.1010614.
The vaccinia-based Sementis Copenhagen Vector coronavirus disease 2019 vaccine induces broad and durable cellular and humoral immune responses.
Eldi P, Cooper T, Prow N, Liu L, Heinemann G, Zhang V
Immunol Cell Biol. 2022; 100(4):250-266.
PMID: 35188985
PMC: 9111635.
DOI: 10.1111/imcb.12539.
A generic protocol for the affinity-purification of native macromolecular complexes from poxvirus-infected cells.
Bartuli J, Lorenzi I, Backes S, Grimm C, Fischer U
STAR Protoc. 2022; 3(1):101116.
PMID: 35118428
PMC: 8792428.
DOI: 10.1016/j.xpro.2021.101116.
Impact of Molecular Modifications on the Immunogenicity and Efficacy of Recombinant Raccoon Poxvirus-Vectored Rabies Vaccine Candidates in Mice.
Malave C, Lopera-Madrid J, Medina-Magues L, Rocke T, Osorio J
Vaccines (Basel). 2021; 9(12).
PMID: 34960182
PMC: 8708037.
DOI: 10.3390/vaccines9121436.